Cerebrolysin
5ml · 99%+ Purity
Description
Cerebrolysin is a peptide mixture with neurotrophic-like effects, studied for its potential to support neuronal survival and synaptic plasticity. Research explores its impact on cognitive function and neurodegenerative conditions like Alzheimer's.
Disclaimer: The images on this page are for illustrative purposes only. Peptodio is an educational resource and does not sell any products, nor will we ever. We do not recommend or endorse any sellers or vendors. This information is provided for research and educational purposes only.
Research & Science
Evidence-based information about this compound
Cerebrolysin is a peptide preparation derived from pig brain tissue through enzymatic breakdown. It contains a complex mixture of low-molecular-weight neuropeptides (less than 10 kDa) and free amino acids that can cross the blood-brain barrier.
The preparation includes fragments of neurotrophic factors and other brain-derived compounds that have demonstrated neurotrophic and neuroprotective properties. It has been used clinically for decades in many countries for various neurological conditions.
Cerebrolysin represents a multi-target approach to neurological support, with its complex composition affecting multiple pathways simultaneously.
Cerebrolysin's effects stem from multiple mechanisms:
- Neurotrophic Support: Contains fragments with neurotrophic factor-like activity.
- Neuroplasticity: Enhances synaptic plasticity and dendritic spine formation.
- Neuroprotection: Protects neurons from various forms of damage.
- Anti-Apoptotic: Reduces programmed cell death in neurons.
- Neurogenesis: May support new neuron formation in certain regions.
Cerebrolysin's neurotrophic effects are well-documented:
- Neurite Outgrowth: Promotes growth of neuronal processes in cell cultures.
- Synaptogenesis: Enhances formation of new synaptic connections.
- Brain Repair: Supports neuronal survival and repair mechanisms.
- Cognitive Function: Associated with improved cognitive outcomes in clinical studies.
These effects underlie its use in neurodegenerative and neurological injury research.
Cerebrolysin has extensive clinical research:
- Stroke Recovery: Multiple trials in acute ischemic stroke.
- Alzheimer's Disease: Studied for cognitive improvement in AD patients.
- Traumatic Brain Injury: Research in TBI recovery.
- Vascular Dementia: Investigated for cognitive support.
It is approved in numerous countries for neurological conditions.
Sources:
This information is provided for educational purposes only and is based on published scientific research. This product is intended for research use only.
